Literature DB >> 7526648

Inhibitory effect of interleukin-2 on histamine release from rat mast cells.

K Tasaka1, M Hamada, M Mio.   

Abstract

Interleukin-2 (IL-2) inhibited histamine release from rat mast cells induced by compound 48/80 in a concentration-dependent manner. The inhibitory effect of IL-2 on histamine release was also dependent on the length of the incubation period; the maximum inhibition was achieved at 8 h after IL-2 addition. Furthermore, IL-2 inhibited not only IP3 production but also 45Ca uptake in mast cells stimulated by compound 48/80. Since IL-2 enhanced [3H]-leucine uptake into mast cells, this suggests that protein synthesis may be related in some way with the inhibition of histamine release. IL-2 treatment augmented the synthesis of a protein having a molecular weight of approximately 35 kDa. From Western blotting analysis, it became clear that the production of lipocortin-I was augmented in rat mast cells by IL-2 treatment. The present study shows that IL-2 induces the synthesis of lipocortin-I in mast cells and that lipocortin-I may play some role in inhibiting histamine release from mast cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7526648     DOI: 10.1007/bf02007751

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  5 in total

1.  Lipocortin I and lipocortin II inhibit phosphoinositide- and polyphosphoinositide-specific phospholipase C. The effect results from interaction with the substrates.

Authors:  K Machoczek; M Fischer; H D Söling
Journal:  FEBS Lett       Date:  1989-07-17       Impact factor: 4.124

2.  Mast cell growth-enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFIII (interleukin 9).

Authors:  L Hültner; C Druez; J Moeller; C Uyttenhove; E Schmitt; E Rüde; P Dörmer; J Van Snick
Journal:  Eur J Immunol       Date:  1990-06       Impact factor: 5.532

3.  Recombinant human IL-1 alpha and -1 beta potentiate IgE-mediated histamine release from human basophils.

Authors:  W A Massey; T C Randall; A Kagey-Sobotka; J A Warner; S M MacDonald; S Gillis; A C Allison; L M Lichtenstein
Journal:  J Immunol       Date:  1989-09-15       Impact factor: 5.422

4.  Characterization of a T cell-derived lymphokine that acts synergistically with IL 3 on the growth of murine mast cells and is identical with IL 4.

Authors:  E Schmitt; B Fassbender; K Beyreuther; E Spaeth; R Schwarzkopf; E Rüde
Journal:  Immunobiology       Date:  1987-08       Impact factor: 3.144

5.  Human recombinant granulocyte-macrophage colony-stimulating factor and interleukin 3 cause basophil histamine release.

Authors:  M Haak-Frendscho; N Arai; K Arai; M L Baeza; A Finn; A P Kaplan
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

  5 in total
  1 in total

Review 1.  Annexin-A1: a pivotal regulator of the innate and adaptive immune systems.

Authors:  F D'Acquisto; M Perretti; R J Flower
Journal:  Br J Pharmacol       Date:  2008-07-21       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.